Gabriel Chow
Queen's Medical Centre(GB)
Publications by Year
Research Areas
DNA Repair Mechanisms, Genetic Neurodegenerative Diseases, Epilepsy research and treatment, Muscle Physiology and Disorders, Cell Adhesion Molecules Research
Most-Cited Works
- → The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial(2021)207 cited
- → Genotype–phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations(2010)203 cited
- → The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial(2021)185 cited
- → Neurological Manifestations of Influenza Infection in Children and Adults: Results of a National British Surveillance Study(2013)184 cited
- → Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial(2018)163 cited
- → Clinical features, course, and outcomes of a UK cohort of pediatric moyamoya(2018)116 cited
- → SEPN1 -related myopathies(2011)82 cited
- → Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain(2015)78 cited
- → The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations(2019)50 cited
- → Longitudinal analysis of the neurological features of ataxia‐telangiectasia(2016)46 cited